Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome.

Arch Dis Child Fetal Neonatal Ed · 2022 · PMC8685619 · PMID 34112722

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp=0.10so close (0.05 < p ≤ 0.1)

Kaplan-Meier analysis of patients in part 2 showed a trend towards decreased rate of study failure in the AeroFact-treated infants compared with historical controls (p=0.10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.